@techcrunch.com 2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com 4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com 4 years ago
Risks and rewards of digital therapeutics in treating mental disorders
@techcrunch.com 7 years ago
Cannabis investor Privateer Holdings tacks on another $40 million in funding